Evidence map›Paper›PMID 41447092›Full record

ArticleFASEB journal : official publication of the Federation of American Societies for Experimental Biology2026

The CCL11-CCR3 Axis Regulates the Aggravation of Neuroinflammation in Astrocytic Necroptosis After Cerebral Ischemia.

Han Yin, Xinmin Zhang, Meng Li, Yunzhe Liu, Yingying Zhang, Yao Zhang, Hui Ci, Kun Li, ShanShan Yang, Guangyou Wang and 1 more

Abstract read
In one paragraph

Article in FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. The CCL11-CCR3 Axis Regulates the Aggravation of Neuroinflammation in Astrocytic Necroptosis After Cerebral Ischemia.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2026
    Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Han YinDepartment of Neurobiology, Heilongjiang Provincial Key Laboratory of Neurobiology, Harbin Medical University, Harbin, People's Republic of China.
Xinmin ZhangDepartment of Neurobiology, Heilongjiang Provincial Key Laboratory of Neurobiology, Harbin Medical University, Harbin, People's Republic of China.
Meng LiDepartment of Neurology, The First Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang, People's Republic of China.
Yunzhe LiuDepartment of Pathophysiology, Heilongjiang Provincial Key Laboratory of Neurobiology, Harbin Medical University, Harbin, People's Republic of China.
Yingying ZhangDepartment of Neurobiology, Heilongjiang Provincial Key Laboratory of Neurobiology, Harbin Medical University, Harbin, People's Republic of China.
Yao ZhangDepartment of Neurobiology, Heilongjiang Provincial Key Laboratory of Neurobiology, Harbin Medical University, Harbin, People's Republic of China.
Hui CiDepartment of Neurobiology, Heilongjiang Provincial Key Laboratory of Neurobiology, Harbin Medical University, Harbin, People's Republic of China.
Kun LiDepartment of Neurobiology, Heilongjiang Provincial Key Laboratory of Neurobiology, Harbin Medical University, Harbin, People's Republic of China.
ShanShan YangDepartment of Neurology, The First Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang, People's Republic of China.
Guangyou WangDepartment of Neurobiology, Heilongjiang Provincial Key Laboratory of Neurobiology, Harbin Medical University, Harbin, People's Republic of China.
Tongshuai ZhangDepartment of Neurobiology, Heilongjiang Provincial Key Laboratory of Neurobiology, Harbin Medical University, Harbin, People's Republic of China.ORCID 0009-0002-4988-2801

Funding

MOST | National Natural Science Foundation of China (NSFC) 32071036MOST | National Natural Science Foundation of China (NSFC) 82101409| Natural Science Foundation of Heilongjiang Province (Heilongjiang Natural Science Foundation) ZD2022H001
6 · The paper itself

Abstract

In ischemic stroke (IS), the programmed death of neurons is a key factor contributing to poor prognosis and neurological dysfunction. Recently, it has been discovered that necroptosis, as a form of programmed cell death, promotes neuroinflammatory damage after IS; however, its mechanism is still unclear. Recent studies have shown that CCL11, as an eosinophil chemokine, may induce neuronal cytotoxicity by triggering the production of reactive oxygen species (ROS) in microglia. Meanwhile, CCR3, serving as the major functional membrane receptor target of CCL11, plays a crucial role in transducing CCL11 signals. This study establishes a mouse model of IS using permanent middle cerebral artery ligation (pMCAL) and utilizes methods such as Western blot (WB), quantitative polymerase chain reaction (qPCR), and immunofluorescence (IF) to detect changes in necroptosis markers and chemokines. The aim was to analyze the dynamic progression of necroptosis after stroke and its potential regulatory mechanisms. In in vivo experiments, the recovery levels of necroptosis and neuroinflammation were observed by administering a C-C motif chemokine receptor 3 (CCR3) inhibitor via cerebral stereotaxic injection. In vitro experiments utilized an oxygen-glucose deprivation (OGD) model to simulate the in vivo ischemic state of astrocytes. Exogenous CCL11 was administered, and the expression of CCR3 on astrocytes was inhibited to observe changes in necroptosis and apoptosis markers, including receptor-interacting protein kinase 1 (RIPK1), receptor-interacting protein kinase 1 (RIPK3), and mixed lineage kinase domain-like protein (MLKL), as well as inflammatory factors interleukin-1 beta (IL-1β), NOD-like receptor thermal protein domain-associated protein 3 (NLRP3), and apoptosis-associated speck-like protein containing a CARD(ASC). The results indicated that CCL11 stimulation significantly activated necroptosis and apoptosis in astrocytes, while blocking the CCR3 receptor on astrocytes resulted in a significant inhibition of this process. By collecting supernatants from various groups of astrocytes and stimulating neurons, it was further observed that necroptosis, induced by CCL11-CCR3 stimulation, significantly disrupts synaptic connections in neurons. We conclude that the CCL11-CCR3 axis plays a key role in the necroptosis of astrocytes after IS.

Indexed as

AstrocytesBrain IschemiaChemokine CCL11NecroptosisNeuroinflammatory DiseasesReceptors, CCR3AnimalsMaleMiceMice, Inbred C57BLSignal TransductionCcl11 protein, mouseCcr3 protein, mouseChemokine CCL11Receptors, CCR3astrocytesCCL11CCR3necroptosisneuroinflammation

Identifiers

PMID41447092
PMCPMC12739800

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.